AVE Science & Technology Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005188
CNY
20.21
-0.55 (-2.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
AVE Science & Technology Co., Ltd.

Why is AVE Science & Technology Co., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 2.16%
  • The company has been able to generate a Return on Capital Employed (avg) of 2.16% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
  • Poor long term growth as Net Sales has grown by an annual rate of 1.65% and Operating profit at 14.27% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Equity (avg) of 4.79% signifying low profitability per unit of shareholders funds
3
Positive results in Sep 25
  • OPERATING CASH FLOW(Y) Highest at CNY 46.52 MM
  • ROCE(HY) Highest at 5.3%
  • DIVIDEND PAYOUT RATIO(Y) Highest at 23.93%
4
With ROE of 5.02%, it has a expensive valuation with a 3.41 Price to Book Value
  • Over the past year, while the stock has generated a return of 43.20%, its profits have risen by 6.1% ; the PEG ratio of the company is 11.1
5
Market Beating performance in long term as well as near term
  • Along with generating 43.20% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to AVE Science & Technology Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is AVE Science & Technology Co., Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
AVE Science & Technology Co., Ltd.
-5.65%
2.92
32.80%
China Shanghai Composite
19.22%
1.58
14.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
1.26%
EBIT Growth (5y)
1.10%
EBIT to Interest (avg)
7.47
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.41
Tax Ratio
2.56%
Dividend Payout Ratio
35.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.16%
ROE (avg)
4.79%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.60
EV to EBIT
7.80
EV to EBITDA
5.26
EV to Capital Employed
0.41
EV to Sales
0.66
PEG Ratio
0.46
Dividend Yield
NA
ROCE (Latest)
5.20%
ROE (Latest)
5.68%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 45.15 MM

NET PROFIT(HY)

At CNY 6.71 MM has Grown at 68.58%

ROCE(HY)

Highest at 5.85%

RAW MATERIAL COST(Y)

Fallen by -12% (YoY

-5What is not working for the Company
INTEREST(9M)

At CNY 0.17 MM has Grown at inf%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.96 times

Here's what is working for AVE Science & Technology Co., Ltd.

Operating Cash Flow
Highest at CNY 45.15 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit
At CNY 6.71 MM has Grown at 68.58%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Raw Material Cost
Fallen by -12% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for AVE Science & Technology Co., Ltd.

Interest
At CNY 0.17 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio
Lowest at 1.96 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio